Trade Show News

MONTREAL--(BUSINESS WIRE)--Mandatory and NuORDER by Lightspeed, the industry’s leading B2B commerce platform, are joining forces for the third consecutive time to power the digital extension of Mandatory’s in-person trade event, taking place August 5–7 in Copenhagen. This renewed partnership reflects the continued momentum behind hybrid commerce—where physical and digital trade intersect to create smarter, more flexible buying experiences. As the Nordic fashion ecosystem expands with energy and...

NEW YORK--(BUSINESS WIRE)--Please remove the partners listed under "Real-world (rw) ctDNA testing trends and associated outcomes in patients (pts) with early stage breast cancer (EBC)." The updated release reads: FLATIRON HEALTH ANNOUNCES RESEARCH TO BE PRESENTED AT ASCO 2025 Flatiron’s 2025 ASCO research showcases the power of longitudinal, real-world oncology data and innovative AI-driven methodologies to generate actionable evidence, address health equity, and accelerate progress in cancer c...

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced results from an expansion cohort of the phase 1b/2 STELLAR-002 trial evaluating zanzalintinib in combination with either nivolumab (Opdivo®) or a fixed-dose combination of nivolumab and relatlimab (Opdualag™) in patients with previously untreated advanced clear cell renal cell carcinoma (RCC). These findings, as well as data from multiple dose-escalation cohorts from STELLAR-002, will be presented at the 2025 Americ...

COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) announced today that it will present new research from its comprehensive development program evaluating its late-stage portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from May 30 to June 3 in Chicago, Illinois. The presentations will include the first disclosure of results from a Phase 1/2 trial evaluating rinatabart sesutecan (Rina-S®), an investigational folate receptor-alpha (FRa)-...

BOSTON--(BUSINESS WIRE)--Foundation Medicine shares details on the 15+ abstracts the company and its collaborators will present at the 2025 ASCO® Annual Meeting....

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) will present new clinical research across its oncology portfolio with more than 20 abstracts in multiple cancers at the 2025 American Society of Clinical Oncology Scientific Program (#ASCO25). Data at ASCO showcasing the company’s progress towards creating new standards of care for patients with cancer will include two late-breaking oral presentations. The first will feature results of the DESTINY-Breast09 phase 3 trial (LBA #1008...

ALPHARETTA, Ga.--(BUSINESS WIRE)--Agilysys, Inc., (Nasdaq: AGYS), a leading global provider of hospitality software solutions that enable organizations to go beyond what they can accomplish with traditional property management systems (PMS), point-of-sale (POS) solutions and food-and-beverage inventory and procurement (F&B I&P) systems, today announced it will participate in the William Blair 45th Annual Growth Stock Conference to be held in person, in Chicago, Illinois, June 3rd – June...

LOS ANGELES--(BUSINESS WIRE)--Grindr Inc. (NYSE: GRND), the Global Gayborhood in Your Pocket™, today announced that Vanna Krantz, Grindr’s Chief Financial Officer, will participate in a fireside chat at the upcoming TD Cowen 53rd Annual Technology, Media & Telecom Conference in New York, NY on Thursday, May 29, 2025, at 10:50 AM ET. A live webcast of the fireside chat will be made available on Grindr’s investor relations website at https://investors.grindr.com/. An archived replay of the we...

TUSTIN, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company’s Chair and Chief Executive Officer, Michael Costa, the company’s Chief Financial Officer, Talya Nevo-Hacohen, the company’s Chief Investment Officer, Darrin Smith, the company’s Executive Vice President of Investments, and Lukas Hartwich, the company’s Executive Vice President of Finance, will participate in Nareit’s REITweek 2025 Investor Conference June 2 – 5, 2025 at th...

LOS ANGELES--(BUSINESS WIRE)--Korn Ferry (NYSE: KFY) today announced it is participating in the William Blair 45th Annual Growth Stock Conference on Wednesday, June 4, 2025. Korn Ferry EVP, Chief Financial Officer and Chief Corporate Officer Robert Rozek will participate in a presentation beginning at 1:40 p.m. EDT. The event will be broadcast live and accessible to the general public here. The event can also be accessed through Korn Ferry’s Investor Relations website: Investor Relations: Korn...